On January 20th, our CEO Carlos de Sousa participated at Redeye #FightCancer Outlook 2022 with some of the leading #Nordicbiotech companies in this field gifing updates on their priorities, challenges, and expected progress during 2022.
The Redeye Fight Cancer – Outlook 2022 event is now ready for replay. Carlos starts at ca 2:45.